Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies : are we on the right path to the finish line?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 30(2024), 3 vom: 01. März, Seite 270-275 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sassine, Joseph [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cellular therapies |
|---|
| Anmerkungen: |
Date Completed 20.02.2024 Date Revised 04.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cmi.2023.09.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362393028 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362393028 | ||
| 003 | DE-627 | ||
| 005 | 20240304231946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cmi.2023.09.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1316.xml |
| 035 | |a (DE-627)NLM362393028 | ||
| 035 | |a (NLM)37742829 | ||
| 035 | |a (PII)S1198-743X(23)00475-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sassine, Joseph |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies |b are we on the right path to the finish line? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.02.2024 | ||
| 500 | |a Date Revised 04.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cellular therapies | |
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Hematopoietic cell transplantation | |
| 650 | 4 | |a Immunocompromised patients | |
| 650 | 4 | |a Respiratory viral infections | |
| 700 | 1 | |a Hirsch, Hans H |e verfasserin |4 aut | |
| 700 | 1 | |a Chemaly, Roy F |e verfasserin |4 aut | |
| 700 | 0 | |a European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases |d 1995 |g 30(2024), 3 vom: 01. März, Seite 270-275 |w (DE-627)NLM094580014 |x 1469-0691 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:270-275 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cmi.2023.09.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2024 |e 3 |b 01 |c 03 |h 270-275 | ||